Antibody-drug conjugate news and latest updates

News and Trends 6 Mar 2025

Top biotech deals of February 2025

Find out about the top biotech partnership deal of February 2025. Small molecules, T-cell engagers, and RNA medicines, were all part of major collaborations.

March 6, 2025 - 9 minutesmins - By Roohi Mariam Peter

News and Trends 6 Feb 2025

Top biotech deals of January 2025

January 2025 kicked off in full swing with several biotech deals in the biopharma industry.

February 6, 2025 - 8 minutesmins - By Roohi Mariam Peter

In Depth 4 Feb 2025

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer care in 2025.

February 4, 2025 - 14 minutesmins - By Roohi Mariam Peter

News and Trends 12 Dec 2024

Top biotech deals of November 2024

November has seen a variety of biotech deals take place to advance therapies across different stages in development.

December 12, 2024 - 9 minutesmins - By Roohi Mariam Peter

Reports

Produced by Inpart

11 Dec 2024

Antibody Therapy R&D trends and breakthrough innovations

Check out a new report exploring R&D trends and breakthrough innovations leveraging antibodies to create potentially game-changing therapies, published by our parent company Inpart.

December 11, 2024

Produced by Inpart

Harnessing antibody-drug conjugates (ADCs) in oncology: Pathways to clinical success

Discover how ADCs are advancing oncology, the regulatory challenges they face, and the promise they hold for the future of cancer treatment.

November 26, 2024 - 8 minutesmins - By Will Chu

Best in Biotech 14 Nov 2024

8 biotech companies advancing new treatments for breast cancer in 2024

Delve into the diverse landscape of breast cancer treatment with nine biotech companies currently developing new treatments.

November 14, 2024 - 12 minutesmins - By Jules Adam

News and Trends 4 Nov 2024

Top biotech deals of October 2024

Discover the major biotech partnerships, collaborations and mergers and acquisitions that made headlines in October 2024.

November 4, 2024 - 8 minutesmins - By Roohi Mariam Peter

Podcast 11 Oct 2024

Bispecific ADCs: the next generation of cancer treatments

To talk about bispecific ADCs, and biotechs in Czechia, our conversation this week is with Radek Špíšek, CEO of SOTIO.

October 11, 2024

ADCs that deliver: The secret lies in rigorous characterization

Explore the challenges of ADC characterization, key techniques, and the benefits of partnering with a CDMO for effective development.

September 17, 2024 - 7 minutesmins - By Ute Boronowsky

News and Trends 4 Sep 2024

2024: a year of breakthroughs for endometrial cancer?

New treatments have been approved by regulators for endometrial cancer, which are regarded as major therapeutic breakthroughs.

September 4, 2024 - 7 minutesmins - By Roohi Mariam Peter

Podcast 21 Jun 2024

How ADCs can deliver death cap mushroom toxins to treat cancer

Listen to our conversation with Heidelberg Pharma about its lead amanitin-based ADC product candidate, HDP-101.

June 21, 2024

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Antibody-drug conjugates

Top biotech deals of February 2025

Top biotech deals of January 2025

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

Top biotech deals of November 2024

Antibody Therapy R&D trends and breakthrough innovations

Harnessing antibody-drug conjugates (ADCs) in oncology: Pathways to clinical success

8 biotech companies advancing new treatments for breast cancer in 2024

Top biotech deals of October 2024

Bispecific ADCs: the next generation of cancer treatments

ADCs that deliver: The secret lies in rigorous characterization

2024: a year of breakthroughs for endometrial cancer?

How ADCs can deliver death cap mushroom toxins to treat cancer

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!